Researchers at the University of Alberta’s have explained how the function of a key protein in the heart changes in heart failure. The study is published in the in Proceedings of the National Academy of Sciences.
The molecular structure of the heart muscle changes as heart failure progresses, though scientists cannot always agree on what changes are good or bad. One change that occurs is an increase in ‘calcium sensitivity’. Calcium ions are pumped in and out of the muscle cell with each heartbeat, turning contractions on and off. When the calcium sensitivity increases, contractility increases, but at a price; the relaxation of the heart becomes slower. Both phases of cardiac function are important, impaired contraction leads to systolic heart failure, while impaired relaxation leads to diastolic heart failure. Both types of heart failure are similar in terms of overall prevalence, symptoms and mortality.
Since 1976 medical researchers have known that the heart regulates its calcium sensitivity by phosphorylating (adding negative phosphate groups) to a key cardiac protein called troponin I. The troponin complex is made up of three proteins, C, I, and T, which trigger muscle contraction in response to calcium. In heart failure, the phosphate groups are removed from troponin I, but it wasn’t known how this caused an increase in calcium sensitivity.
In the current study the researchers studied the troponin complex with nuclear magnetic resonance (NMR) spectroscopy, a powerful method that uses superconducting magnets to probe atomic level structure. They observed that unphosphorylated troponin I binds to troponin C to keep it in an optimal orientation for triggering contraction. The (N-terminal) region of troponin I that interacts with troponin C is very positively charged, while troponin C is very negatively charged, so adding negative phosphate groups to troponin I disrupts the interaction and releases troponin C so that it becomes less efficient at triggering contraction.
Scientists believed that the dephosphorylation of troponin I seen in heart failure somehow caused the troponin complex to become less functional. Actually, the change brings it into the optimal alignment to trigger contraction. The heart has other mechanisms of regulating calcium sensitivity that probably also act by stabilizing or disrupting this arrangement.
The team hypothesizes that the heart continuously adjusts calcium sensitivity in order to maintain a proper balance between contraction and relaxation.
The team believe that calcium sensitivity will become a central concept in cardiology. The increase in calcium sensitivity seen in heart failure may be the heart’s response to ongoing volume or pressure overload. While this would be a beneficial compensation in the setting of systolic heart failure, it is probably not helpful in diastolic heart failure.
Heart disease is the number-one killer in the developed world. The end stage of heart disease is heart failure, in which the heart cannot pump enough blood to satisfy the body’s needs. Patients become progressively short of breath as the condition worsens, and they also begin to accumulate fluid in the legs and lungs, making it even more difficult to breathe.
The team is now developing troponin-targeting drugs that modulate calcium sensitivity for the treatment of heart failure.
Source: University of Alberta
calcium sensitivity, cardiac, dilated cardiomyopathy, fuzzy complex, healthinnovations, heart failure, hypertrophic cardiomyopathy, post-translational modification, troponin C, troponin complex, troponin I
Michelle is a health industry veteran who taught and worked in the field before training as a science journalist.
Featured by numerous prestigious brands and publishers, she specializes in clinical trial innovation--expertise she gained while working in multiple positions within the private sector, the NHS, and Oxford University.